Squarepoint’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8M Buy
60,300
+39,400
+189% +$11.7M 0.02% 772
2025
Q4
$5.71M Sell
20,900
-36,200
-63% -$9.84M 0.01% 1378
2025
Q3
$15.4M Sell
57,100
-115,400
-67% -$31.4M 0.02% 871
2025
Q2
$47.5M Buy
172,500
+43,600
+34% +$11.9M 0.05% 414
2025
Q1
$34.2M Buy
128,900
+86,700
+205% +$21.4M 0.04% 462
2024
Q4
$9.8M Buy
42,200
+40,600
+2,538% +$9.34M 0.01% 1170
2024
Q3
$353K Sell
1,600
-24,100
-94% -$4.99M ﹤0.01% 3343
2024
Q2
$5.05M Buy
+25,700
New +$5.31M 0.01% 1378
2023
Q4
Sell
-7,100
Closed -$1.42M 4053
2023
Q3
$1.42M Buy
+7,100
New +$1.41M ﹤0.01% 2068
2021
Q4
Sell
-21,100
Closed -$4.08M 3204
2021
Q3
$4.08M Sell
21,100
-6,000
-22% -$1.22M 0.01% 872
2021
Q2
$5.76M Buy
27,100
+17,400
+179% +$3.67M 0.02% 662
2021
Q1
$1.98M Sell
9,700
-8,300
-46% -$1.63M 0.01% 1075
2020
Q4
$3.28M Buy
+18,000
New +$3.06M 0.02% 665

Other funds holding CME

Squarepoint's CME Position: Q1 2026 in Review

Squarepoint increased its CME Group (CME) stake by 122% in Q1 2026, buying an estimated $19.8M and bringing the position to 121,196 shares worth $35.8M. The position accounts for 0.04% of the portfolio, ranked #447.

Squarepoint first reported a position in CME in Q2 2015 and has held it in 42 quarters since. The position peaked at $72.7M in Q4 2022. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Squarepoint held 121,196 shares of CME Group worth $35.8M as of Q1 2026.
  • Squarepoint bought 66,586 CME Group shares in Q1 2026, an estimated $19.8M.
  • CME Group made up 0.04% of Squarepoint's portfolio in Q1 2026, its #447 holding.
  • Squarepoint first reported a position in CME Group in Q2 2015 and has held it in 42 quarters since.
  • Squarepoint's CME Group position peaked at $72.7M in Q4 2022.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.